Expression of Cyclins D1 and D3 and Ki-67 in Non-Hodgkin's Lymphomas of B-cell Lineage
. | Ki-67 . | Cyclin D3 . | Cyclin D1 . |
---|---|---|---|
MCL | 38.2 ± 21.7 | <5%* | 42.7 ± 32.0 |
CLL | 16.9 ± 10.5 | 9.0 ± 4.9 | negative |
MALT | 20.0 ± 27.6 | 5.9 ± 4.9 | negative |
FCL | 36.5 ± 18.1 | 12.1 ± 7.3 | negative |
DLBL | 69.8 ± 21.1 | 38.1 ± 29.8 | negative |
. | Ki-67 . | Cyclin D3 . | Cyclin D1 . |
---|---|---|---|
MCL | 38.2 ± 21.7 | <5%* | 42.7 ± 32.0 |
CLL | 16.9 ± 10.5 | 9.0 ± 4.9 | negative |
MALT | 20.0 ± 27.6 | 5.9 ± 4.9 | negative |
FCL | 36.5 ± 18.1 | 12.1 ± 7.3 | negative |
DLBL | 69.8 ± 21.1 | 38.1 ± 29.8 | negative |
Values represent mean percentage of labeled cells and standard deviation. Ki-67 and cyclin D3 are positively correlated (0.969).
Abbreviations: MCL, mantle cell lymphoma; CLL, chronic lymphocyte lymphoma; MALT, mucosa-associated lymphatic tissue; FCL, follicular cell lymphoma; DLBL, diffuse large B-cell lymphoma.
Only CD45R0-positive T cells and/or reactive B cells of germinal centers expressed cyclin D3.